Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Takuya InoueDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0009-0008-8434-3567
Nobuhiro KanajiDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0000-0001-7365-4927
Takafumi NakamuraDivision of Genomic Medicine, Department of Genomic Medicine and Regenerative Therapeutics, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.ORCID 0000-0002-0196-0754
Masanao YokohiraDepartment of Medical Education, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0000-0002-8117-0495
Yuta KomoriDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0009-0009-5715-2738
Yasuhiro OharaDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0009-0008-0712-0183
Hitoshi MizoguchiDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Naoki WatanabeDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0000-0002-6418-991X
Norimitsu KadowakiDivision of Hematology, Faculty of Medicine, Department of Internal Medicine, Kagawa University, Takamatsu 761-0793, Japan.ORCID 0000-0002-6473-800X
Funding
Japan Society for the Promotion of Science JP19K08653
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells. · full record | OpenQuestion